SCHEMBL16100156

SCHEMBL16100156

COC(=O)CCNCc1cc(-c2cc(Cl)ccc2Oc2cc(F)c(S(=O)(=O)N(Cc3ccc(OC)cc3OC)c3ncns3)cc2Cl)ccn1

nearest known ligand 0.48

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
SCN9A Q15858 20/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16100158 0.90 SCN9A (0.45) SCN9A
SCHEMBL17509684 0.86 SCN9A (0.45) SCN9A
SCHEMBL1094007 0.84 SCN9A (0.48) SCN9A
SCHEMBL17509689 0.83 SCN9A (0.45) SCN9A
SCHEMBL9924648 0.79 SCN9A (0.45) SCN9A
SCHEMBL16011228 0.76 SCN9A (0.52) SCN9A
SCHEMBL10185423 0.76 SCN9A (0.51) SCN9A
SCHEMBL10185455 0.76 SCN9A (0.49) SCN9A
SCHEMBL29736437 0.76 SCN9A (0.40) SCN9A
SCHEMBL1093593 0.76 SCN9A (0.40) SCN9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3193610-A1 SELECTIVE NAV1.7 INHIBITORS FOR THE TREATMENT OF DIABETES Chromocell Corporation (US) 2017-07-26 EP disclosed
EP-3043787-A2 SODIUM CHANNEL MODULATORS FOR THE TREATMENT OF PAIN AND DIABETES Chromocell Corporation (US) 2016-07-20 EP disclosed
WO-2016040315-A1 SELECTIVE NAV1.7 INHIBITORS FOR THE TREATMENT OF DIABETES CHROMOCELL CORPORATION (US) 2016-03-17 WO disclosed
EP-2968234-A1 SODIUM CHANNEL MODULATORS FOR THE TREATMENT OF PAIN Chromocell Corporation (US) 2016-01-20 EP disclosed
WO-2014151472-A1 SODIUM CHANNEL MODULATORS FOR THE TREATMENT OF PAIN CHROMOCELL CORPORATION (US) 2014-09-25 WO disclosed